small win: Ozempic stopped being a problem at week 70
Something I noticed reading old threads that I have not seen said out loud. The advice on weekly dosing in this community changed substantially around the start of last year, and nobody went back and updated the older posts. So depending on which thread the search engine hands you, you get two contradictory answers…
titration speed is Wegovy plus side effects, period
week 60 and i am still not at maintenance, do not rush the ladder
Ozempic versus Wegovy versus research grade is the wrong argument, they are literally the same molecule
week 60 and i am still not at maintenance, do not rush the ladder
Counter-anecdote: opposite result, same dose. Which mostly tells us the variance is huge.
pens are overpriced, research vials are research grade, same molecule different price
week 9 and i am still not at maintenance, do not rush the ladder
my eGFR moved before the scale did and i nearly missed it
Inter-lab variance on this kind of assay is routinely 1–2 points. Different column, different gradient, different integration.
the quiet is real. the food noise just stops.